PMID- 8760279 OWN - NLM STAT- MEDLINE DCOM- 19960924 LR - 20190826 IS - 0161-5890 (Print) IS - 0161-5890 (Linking) VI - 33 IP - 7-8 DP - 1996 May-Jun TI - Tumor necrosis factor-alpha (TNF-alpha) induces a reversible, time- and dose-dependent adhesion of progenitor T cells to endothelial cells. PG - 671-80 AB - Recent in vivo studies suggest that tumor necrosis factor-alpha (TNF-alpha) is involved in the development of the thymus. We postulated that this inflammatory mediator could regulate the influx of progenitor T cells into the thymus. Using an in vitro static adhesion system, we found that TNF-alpha increases the adhesion of a murine progenitor T cell line (FTF1) to a bovine aortic endothelial cell line (1F8), human umbilical vein endothelial (HUVE) cells, and a murine arterial endothelial (MAE) cell line. TNF-alpha treatment of the 1F8 cells resulted in a time- and dose-dependent increase in the adherence of FTF1 cells. Adherence increased during the first 6 hr of treatment with TNF-alpha concentrations ranging from 10(-11) to 10(-9) M. Maximal adherence (6 hr treatment with 10(-10) M of TNF-alpha) was approximately 4.5-fold larger than that of untreated monolayers. A slow decrease in adherence, down to approximately 2-fold at 48 hr, was observed beyond 12 hr of TNF-alpha treatment; in contrast, removal of TNF-alpha after 6 hr of continued stimulation caused the adherence to return to pre-stimulation levels within 24-30 hr. Adhesion of FTF1 cells to TNF-alpha treated 1F8 cells was almost completely blocked by a monoclonal antibody against murine CD49d (very late antigen-4) expressed on FTF1 cells. TNF-alpha-induced adhesion of FTF1 cells to MAE cells was also blocked by monoclonal antibodies against murine CD49d and CD106 (vascular cell adhesion molecule-1). These results support the notion that local secretion of TNF-alpha could modulate the dynamics of adhesion of progenitor T cells to the thymic endothelium. FAU - Aparicio, C L AU - Aparicio CL AD - Department of Chemical and Biochemical Engineering, Rutgers University, Piscataway, NJ 08855, USA. FAU - Berthiaume, F AU - Berthiaume F FAU - Chang, C C AU - Chang CC FAU - Yarmush, M L AU - Yarmush ML LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - England TA - Mol Immunol JT - Molecular immunology JID - 7905289 RN - 0 (Antibodies, Monoclonal) RN - 0 (Tumor Necrosis Factor-alpha) SB - IM MH - Animals MH - Antibodies, Monoclonal/pharmacology MH - Binding, Competitive/immunology MH - Cattle MH - Cell Adhesion/drug effects/immunology MH - Cell Line MH - Dose-Response Relationship, Immunologic MH - Endothelium, Vascular/cytology/*drug effects/immunology MH - Hematopoietic Stem Cells/*drug effects/immunology MH - Humans MH - Kinetics MH - Mice MH - T-Lymphocytes/*drug effects/physiology MH - Tumor Necrosis Factor-alpha/*pharmacology EDAT- 1996/05/01 00:00 MHDA- 1996/05/01 00:01 CRDT- 1996/05/01 00:00 PHST- 1996/05/01 00:00 [pubmed] PHST- 1996/05/01 00:01 [medline] PHST- 1996/05/01 00:00 [entrez] AID - 10.1016/0161-5890(96)00013-2 [doi] PST - ppublish SO - Mol Immunol. 1996 May-Jun;33(7-8):671-80. doi: 10.1016/0161-5890(96)00013-2.